Clinical Features of Plasmablastic Lymphoma: Case Series From an Asian Tertiary Cancer Center and Literature Review
|
Abstract
HTML
PDF
Suppl1
|
Daniel Ren Yi Yap, Grace Fangmin Tan, Esther Wei Yin Chang, Valerie Shiwen Yang, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamad Farid, Tiffany Tang, Miriam Tao, Soon Thye Lim, Jason Yongsheng Chan
|
71-78 |
doi: https://doi.org/10.14740/jh672
|
Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia
|
Abstract
HTML
PDF
Suppl1
|
Joseph Tuscano, Christina Poh, Aaron Rosenberg, Brian Jonas, Mehrdad Abedi, Gustavo Barisone, Emily Schwab, Kathleen Lundeberg, Paul Kaesberg
|
79-83 |
doi: https://doi.org/10.14740/jh721
|
Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab
|
Abstract
HTML
PDF
|
Nicolas Cilla, Julie Dallemagne, Marie Vanhove, Patrick Stordeur, Serge Motte, Virginie De Wilde
|
84-88 |
doi: https://doi.org/10.14740/jh614
|
Severe Peripheral Neuropathy From Treatment With Arsenic Trioxide in a Patient Suffering From Acute Promyelocytic Leukemia
|
Abstract
HTML
PDF
|
Soren Niemi Helso, Anne Stidsholt Roug, Morten Mork, Eva Futtrup Maksten, Marianne Tang Severinsen
|
89-92 |
doi: https://doi.org/10.14740/jh617
|
Prevalence of Sickle Cell Trait and Rare Hemoglobin Variants in the Metropolitan Washington DC Area
|
Abstract
HTML
PDF
Suppl1
Suppl2
|
Xiaomei Niu, Christian S. Parry, Angela Mason, Barbara Harrison, Seyed Mehdi Nouraie, Tatiana Ammosova, Juan Salomon-Andonie, Patricia A. Oneal, Victor R. Gordeuk, James G. Taylor, Sergei Nekhai
|
93-95 |
doi: https://doi.org/10.14740/jh603
|